Collectively, our assays implied that both inhibitors are very effective to suppress kidney cancer cell growth through reduction of TOPK, MELK, and FOXM1 proteins that may cooperatively constitute a critical signal pathway in kidney cancer cells. Here, PBK is linked to kidney cancer.